Try our beta test site
114 studies found for:    hepatitis c phase 3 | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
Condition: Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
Intervention: Drug: Glecaprevir/Pibrentasvir
2 Recruiting Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV
Condition: Hepatitis C Virus Infection
Intervention: Drug: SOF/VEL
3 Recruiting Swiss HCVree Trial
Conditions: Hepatitis C;   HIV
Interventions: Drug: grazoprevir/elbasvir, ribavirin;   Behavioral: Behavioural Intervention
4 Recruiting Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis
Condition: Hepatitis C Virus Infection
Interventions: Drug: SOF/VEL;   Drug: RBV
5 Not yet recruiting Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection
Conditions: Hepatitis C, Chronic;   Opioid-use Disorder
Intervention: Drug: Sofosbuvir/Velpatasvir
6 Recruiting A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ombitasvir;   Drug: paritaprevir;   Drug: ritonavir;   Drug: dasabuvir;   Drug: ribavirin
7 Not yet recruiting Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.
Condition: Hepatitis C
Interventions: Drug: SOF/VEL for 6 weeks;   Drug: SOF/VEL for 12 weeks
8 Not yet recruiting A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Condition: Hepatitis C Virus (HCV)
Intervention: Drug: Glecaprevir/Pibrentasvir
9 Not yet recruiting Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients
Condition: Hepatitis C
Interventions: Drug: Sofosbuvir/Ledipasvir 12W;   Drug: Sofosbuvir/Ledipasvir plus Ribavirin 12W;   Drug: Sofosbuvir/Ledipasvir 24W;   Drug: Sofosbuvir/Ledipasvir plus Ribavirin 24W
10 Not yet recruiting Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients
Conditions: Hepatitis C;   HIV
Interventions: Drug: Grazoprevir 100 mg/d 8 weeks;   Drug: Elbasvir 50 mg/d 8 weeks;   Drug: Grazoprevir 100 mg/d 12 weeks;   Drug: Elbasvir 50 mg/d 12 weeks
11 Not yet recruiting Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
Conditions: Hepatitis C;   Cirrhosis
Interventions: Drug: Sofosbuvir;   Drug: Ledipasvir;   Drug: Ribavirin
12 Recruiting A Peer-based Mobile-health Intervention to Increase Access and Adherence to Hepatitis C Treatment and HIV Viral Suppression
Conditions: Hepatitis C;   HIV;   Risk Reduction Behavior
Intervention: Behavioral: Peer Mentor
13 Not yet recruiting Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors ("PI") Failures
Condition: Hepatitis C
Interventions: Drug: 12 weeks without Ribavirin;   Drug: 12 weeks with Ribavirin;   Drug: 24 weeks with Ribavirin
14 Recruiting Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Conditions: Hepatitis C;   Alcohol Abuse
Interventions: Other: Web-Based Brief Alcohol Intervention;   Other: Usual Care
15 Recruiting Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia
Conditions: Hepatitis C;   Cryoglobulinemia
Intervention: Drug: Harvoni
16 Recruiting Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients
Condition: Chronic Hepatitis C Infection
Interventions: Drug: sofosbuvir and daclatasvir;   Drug: ledipasvir/sofosbuvir
17 Recruiting Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV
Conditions: Acute Hepatitis C;   Human Immunodeficiency Virus;   Hepatitis C
Intervention: Drug: Grazoprevir/Elbasvir 100mg/50mg
18 Recruiting A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: "3D" regimen;   Drug: "3D" regimen with ribavirin
19 Not yet recruiting Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.
Conditions: Liver Transplantation;   Hepatitis C
Interventions: Drug: Grazoprevir 100 mg/day;   Drug: Elbasvir 50 mg/d;   Drug: Elbasvir 50 mg/day;   Drug: Ribavirin 1200 mg/day
20 Recruiting The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach
Conditions: Hepatitis C;   Drug Abuse, Intravenous
Intervention: Drug: Sofosbuvir/ledispasvir fixed dose combination (SOF + LDP)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.